Reversible thiol-dependent activation of ryanodine-sensitive Ca2+ release channel by etoposide (VP-16) phenoxyl radical

Antioxidants and Redox Signaling

Volumn 2, Issue 1, 2000, Pages 73-82

  Fabisiak, James P ^a,b   Ritov, Vladimir B ^a   Kagan, Valerian E ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' DITHIODIPYRIDINE; ADENOSINE TRIPHOSPHATASE (CALCIUM); CAFFEINE; CALCIUM CHANNEL; CALCIUM ION; CYSTEINE; DITHIOTHREITOL; ETOPOSIDE; MIXED FUNCTION OXIDASE; MONOPHENOL MONOOXYGENASE; OXYGEN RADICAL; PEROXIDASE; PEROXY RADICAL; PHENOL DERIVATIVE; RUTHENIUM RED; RYANODINE; RYANODINE RECEPTOR; THIOL GROUP; THIOL REAGENT;

ANIMAL TISSUE; ARTICLE; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CHANNEL GATING; CONTROLLED STUDY; DRUG CYTOTOXICITY; HINDLIMB; LIPID PEROXIDATION; MEMBRANE VESICLE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SARCOPLASMIC RETICULUM; SKELETAL MUSCLE;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0034075397     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2000.2.1-73     Document Type: Article

References (36)

1. ABRAMSON, J.J., and SALAMA, G. (1989). Critical sulfhydryls regulate calcium release from sarcoplasmic reticulum. J. Bioenerg. Biomemb. 21, 283-294.
2. ABRAMSON, J., TRIMM, J.L., WEDEN, L., and SALAMA, G. (1983). Heavy metals induce rapid calcium release from sarcoplasmic reticulum vesicles isolated from skeletal muscle. Proc. Natl. Acad. Sci. USA 80, 1526-1530.
3. CORBETT, A.H., and OSHEROFF, N. (1993). When good enzymes go bad: Conversion of topoisomerase II to a cellular toxin by antineoplastic drugs. Chem. Res. Toxicol. 6, 585-597.
4. DUBREZ, L., GOLDWASSER, F., GENNE, P., POMMIER, Y., and SOLARY, E. (1995). The role of cell cycle regulation and apoptosis triggering in determining sensitivity of leukemic cells to topoisomerase I and II inhibitors. Leukemia 9, 1013-1024.
5. GOLINO, P., AMBROSIO, G., VILLARI, B., RAGNI, M., FOCACCIO, A., PACE, L., DECLERK, F., CONDORELLI, M., and CHIARIELLO, M. (1993). Endogenous prostaglandin endoperoxides may alter infarct size in the prescence of thromboxane synthase inhibition - studies in a rabbit model of coronary-artery occlusion reperfusion. J. Am. Coll. Cardiol. 21, 493-501.
6. HAIM, R., NEMEC, J., ROMAN, J., and SINHA, B. (1987). Peroxidase-catalyzed metabolism of etoposide (VP-16-213) and covalent binding of reactive intermediates to cellular membranes. Canc. Res. 47, 5835-5840.
7. KAGAN, V.E. (1988). Lipid Peroxidation of Biological Membranes. (Boca Raton, CRC Press).
8. KAGAN, V.E., YALOWICH, J.C., DAY, B.W., GOLDMAN, R., GANTCHEV, T.G., and STOYANOVSKY, D.A. (1994). Ascorbate is the primary reductant of the phenoxyl radical of etoposide (VP-16) in the presence of thiols both in cell homogenates and in model systems. Biochemistry 33, 9651-9660.
9. KALYANARAMAN, B., NEMEC, J., and SINHA, K. (1987). Characterization of free radicals produced during oxidation of etoposide (VP-16) and its catechol and quinone derivatives. An EPR study. Biochemistry 28, 4839-4846.
10. 2+-transport and free radical lipid oxidation in sarcoplasmic reticulum membranes. Proc. Natl. Acad. Sci. USSR 212, 216-219.
11. LIU, G., and PESSAH, I.N. (1994). Molecular interaction between ryanodine receptor and glycoprotein triadin involves redox cycling of functionally important hyperreactive sulfhydryls. J. Biol. Chem. 269, 33028-33034.
12. LIU, G., ABRAMSON, J.J., ZABLE, A.C., and PESSAH, I.N. (1994). Direct evidence for the existence and functional role of hyperreactive sulfhydryls on the ryanodine receptor-triadin complex selectively labeled by the coumarin malemide, 7-diethylamino-3-(4′-maleimidylphenyl)-4-methylcoumarin. Mol. Pharmacol. 45, 189-200.
13. 2+-release channel function. Biochem. J. 337, 345-361.
14. MCCALLUM, G.P., HORTON, J.E., FALKNER, K.C., and BEND, J.R. (1993). Microsomal cytochrome P450 1A1-dependent monooxygenase activity in guinea pig heart - induction, inhibition, and increased activity by addition of exogenous NADPH cytochrome-P450 reductase. Can. J. Physiol. Pharmacol. 71, 151-156.
15. 2+ release from cardiac sarcoplasmic reticulum vesicles. Arch. Biochem. Biophys. 277, 47-55.
16. 2+ release from cardiac sarcoplasmic reticulum. Arch. Biochem. Biophys. 28, 275-283.
17. QUIAO, J.H., WELCH, C.L., XIE, P.Z., FISHBEIN, M.C., and LUSIS, A.J. (1993). Involvement of the tyrosinase gene in the deposition of cardiac lipofuschin in mice -association with aortic fatty streak development. J. Clin. Invest. 92, 2386-2393.
18. RASCHKE, P., BECKER, B.F., LEIPERT, B., SCHWARTZ, L.M., ZAHLER, S., and GERLACH, E. (1993). Post-ishchemic dysfunction of the heart induced by small numbers of neutrophils via formation of hypochlorous acid. Basic Res. Cardiol. 88, 321-339.
19. 2+ release from the sarcolplasmic reticulum terminal cisterns. Biochim. Biophys. Acta 1067, 187-190.
20. 2+ release from the terminal cisterns of skeletal muscle sarcoplasmic reticulum. FEBS Lett. 188, 77-80.
21. 2+-dependent ATPase activity in proteoliposomes, sealed membrane vesicles, and whole cells. Biochim. Biophys. Acta. 1148, 257-262.
22. 2+-ATPase via thiol oxidation by its phenoxyl radical. Arch. Biochem. Biophys. 321, 140-152.
23. 2+ release by acting at the apparent physiological release site in sarcoplasmic reticulum. J. Biol. Chem. 259, 13363-13369.
24. 2+ transport by sarcoplasmic reticulum vesicles. Biochem. Pharmacol. 32, 3465-3477.
25. 2+ release from the sarcoplasmic reticulum of skinned muscle fibers. J. Physiol. 454, 389-420.
26. 2+ metallochromic indicator. Biochemistry 17, 1378-1386.
27. 2+ release channels. Int. Rev. Cytol. 183, 185-270.
28. SLEVIN, M.L. (1991). The clinical pharmacology of etoposide. Cancer 67, 319-329.
29. TEICHER, B.A., HOLDEN, B.A., and ROSE, C.M. (1985). Effect of oxygen on the cytoxicity and antitumor activity of etoposide. J. Natl. Canc. Inst. 75, 1129-1133.
30. TYURINA, Y.Y., TYURIN, V.A., YALOWICH, J.C., QUINN, P.J., CLAYCAMP, H.G., SCHOR, N.F., PITT, B.R., and KAGAN, V. E. (1995). Phenoxyl radicals of etoposide (VP-16) can directly oxidize intracellular thiols: protective versus damaging effects of phenolic antioxidants. Toxicol. Appl. Pharmacol. 131, 277-288.
31. USUI, N., and SINHA, B.K. (1990). Tyrosinase-induced free radical formation from VP-16-213: relationship to cytotoxicity. Free Radical Res. Commun. 10, 287-293.
32. WOLFE, J.T., ROSS, D., and COHEN, G.M. (1994). A role for metals and free radicals in the induction of apoptosis in thymocytes. FEBS Lett. 352, 58-62.
33. XU, L., EU, J. P., MEISSNER, G., and STAMLER, J.S. (1998). Activation of cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science 279, 234-237.
34. 2+ release from skeletal sarcoplasmic reticulum. J. Biol. Chem. 264, 21725-21736.
35. 2+ release channel in sarcoplasmic reticulum. J. Biol. Chem. 264, 21737-21747.
36. 2+ channel/ryanodine receptor: modulation by endogenous effectors, drugs, and disease states. Pharmacol. Rev. 49, 1-51.